STIFEL FINANCIAL CORP - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 33 filers reported holding RANI THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2023$308,645
-2.4%
141,904
+84.9%
0.00%
Q2 2023$316,252
+72.6%
76,760
+116.1%
0.00%
Q1 2023$183,267
-13.0%
35,517
-0.5%
0.00%
Q4 2022$210,584
-46.0%
35,692
-12.3%
0.00%
-100.0%
Q3 2022$390,000
-11.2%
40,695
-4.2%
0.00%0.0%
Q2 2022$439,000
-22.4%
42,495
+1.4%
0.00%0.0%
Q1 2022$566,000
-13.6%
41,900
+4.6%
0.00%0.0%
Q4 2021$655,000
-3.1%
40,050
+5.5%
0.00%0.0%
Q3 2021$676,00037,9500.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$1,073,5450.87%
Alpha Square Group S LLC 86,946$189,1080.19%
LASRY MARC 62,887$136,7790.14%
Alphabet Inc. 448,492$973,2270.06%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$1,034,7950.03%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$20,9040.02%
Activest Wealth Management 9,800$21,3150.01%
Lafayette Investments 19,893$43,2680.01%
MOTCO 48,129$104,6810.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 51,500$112,0130.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders